That subjectivity is the biggest cause for concern, there's nothing to stop the FDA at the next review saying "close, but not quite. See you again in 6 months". There must or should be a mechanism for interim reviews or appeal if you're rejecting based on opinions rather than hard data.
"Power corrupts; absolute power corrupts absolutely"
That subjectivity is the biggest cause for concern, there's...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
-0.015(5.56%) |
Mkt cap ! $401.6M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.5¢ | 25.3¢ | $1.478M | 5.628M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 659131 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 226542 | 3 |
View Market Depth
| Last trade - 16.10pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
25.5¢ |
Change
-0.015 ( 4.89 %) |
||||
| Open | High | Low | Volume | ||
| 27.0¢ | 27.5¢ | 25.3¢ | 3642701 | ||
| Last updated 15.59pm 15/05/2024 ? | |||||
| BOT (ASX) Chart |